Gramicidin S (GS), cyclo(-Val 1,1¢ -Orn 2,2¢ -Leu 3,3¢ -D-Phe 4,4¢ -Pro 5,5¢ -) 2 , 1-3 is a potent cyclopeptide antibiotic isolated from Bacillus brevis. Its secondary structure has been established as an antiparallel b-sheet conformation with amphiphilicity. 4, 5 The conformation is characteristically featured with the orientation of side chains in such a way that the charged Orn side chains are situated on one side of the molecule and the hydrophobic Val and Leu side chains are situated on the other side. The side-chain arrangement is apparently held together by a rigid conformation containing two D-Phe-Pro type II¢ b-turns. It has been proposed that the principal modes of antibiotic actions result from an interaction of GS with the cell membrane of the target microorganisms. GS then adopts an antiparallel b-sheet conformation with amphiphilicity, which disrupts cell membrane. 6 Thus, the hydrophobic Val and Leu residues have been considered to be essential for exhibiting the strong activity of GS. Therefore, syntheses of antimicrobially active analogs of GS containing amino acid residues with hydrophilic side chain in place of Val and Leu residues have not been reported yet. 2, 3, [7] [8] [9] In this account, we designed and synthesized novel GS analogs, cyclo(-Orn 1,1¢ -Orn 2,2¢ -Orn 3,3¢ -D-Phe 4,4¢ -Pro 5,5¢ -) 2 (1) and cyclo (-Lys 1,1¢ -Orn 2,2¢ -Lys 3,3¢ -D-Phe 4,4¢ -Pro 5,5¢ -) 2 (2) , which have four basic amino acid residues (Orn and Lys residues) in place of four hydrophobic amino acid residues (Val and Leu residues), to investigate the role of amphiphilic b-sheet structure of GS for the antibiotic activity.
Syntheses of 1 and 2 were performed by a solid-phase method using oxime resin. 10 The formation of the cyclic peptides by the dimerization-cyclization of H-D-Phe-Pro-X-Orn(Z)-X-oxime on resin (X¼Orn(Z), and Lys(Z)) (Z-¼benzyloxycarbonyl-) gave cyclo(-X 1,1¢ -Orn(Z) 2,2¢ -X 3,3¢ -D-Phe 4,4¢ -Pro 5,5¢ -) 2 in 83 and 92% yields, respectively. The removal of all the masking groups by 25% HBr/AcOH produced the corresponding antibiotics 1 and 2 in 53 and 67% yields, respectively. The homogeneities of 1 and 2 were confirmed by thin-layer chromatography, high performance liquid chromatography, FAB-MS and 1 H NMR spectrometry.
To investigate the secondary structures of 1 and 2, CD and 1 H NMR spectra of 1 and 2 were measured. Compounds 1, 2 and GS showed almost identical CD spectra in methanol (Figure 1 ), suggesting that 1 and 2 have a b-sheet structure similar to that of GS.
The 1 H NMR (400 MHz) spectra of 1 and 2 were measured at 30 1C in DMSO-d6 (peptide concentration: B17 mg ml À1 ). All protons were assigned by means of H-H COSY (correlation spectroscopy), TOCSY (total correlation spectroscopy) and ROESY (rotating frame nuclear Overhauser enhancement spectroscopy). Only one a NH resonance appeared for X 1,1¢ , Orn 2,2¢ , X 3,3¢ and D-Phe 4,4¢ residues (1: X¼Orn, 2: X¼Lys), indicating that 1 and 2 have conformations with C 2 symmetry in the NMR time average. In the 1 showed positive values (40.1 p.p.m.). On the other hand, the D-Phe 4,4¢ and Pro 5,5¢ residues showed negative values. The chemical shift perturbation of the a H of 1 agreed well with those of GS. 13 The results suggested that Orn 1,1¢ -Orn 2,2¢ -Orn 3,3¢ sequences in 1 have a similar b-sheet conformation to that of GS sequences. Next, for detailed analysis, the spatial ROE correlations were measured. Figure 2 , and that the hydrophobic side chains of Val and Leu residues are not necessary for holding the rigid b-sheet conformation of GS.
The antibiotic activities and hemolytic activities of 1, 2 and GS were summarized in Table 1 . The difference of antibiotic activities among 1, 2 and GS reflects the characters of side chains of the amino acid residues at positions 1, 1¢, 3 and 3¢ because the antibiotics have similar b-sheet structure to each other. The antibiotic activities of 1 and 2 were 1/4 and 1/8 of GS against Bacillus subtilis NBRC 3513 and Bacillus megaterium ATCC 19213, respectively, and less against Staphylococcus epidermidis NBRC 12933 and Staphylococcus aureus NBRC 12732. On the other hand, 1 and 2 showed no activity against Gram-negative microorganisms tested. The results indicated that the presence of hydrophobic side chains of Val and Leu residues are important for exhibiting the strong activity of GS. In addition, it is interesting to note that 1 and 2 showed some selectivity against different microorganisms. Then, 1 and 2 showed almost no hemolytic activity toward sheep red blood cells (Table 1 ), 14 indicating that the replacement of the Val and Leu hydrophobic side chains into the Orn and Lys basic side chains could result in substantial reduction of hemolytic activities.
In these studies, we reported the structure-activity relationship of GS analogs 1 and 2 containing Orn and Lys residues with basic side chains in place of four hydrophobic Val and Leu residues. Currently, we are investigating the design and syntheses of other antimicrobially active analogs of GS without the hydrophobic Val and Leu residues on one side of the molecule on the basis of these studies in order to find new types of drug candidates with high antimicrobial and low hemolytic activities.
EXPERIMENTAL SECTION
Melting points were measured on Mel-Temp II melting point apparatus (Laboratory Devices, Cambridge, MA, USA) and are uncorrected. Low-resolution mass spectra (LR-MS) were obtained by using FAB mass spectrometry on a JEOL600H mass spectrometer (Jeol, Tokyo, Japan). CD spectra were recorded on a Jasco J-820 spectropolarimeter (Jasco, Tokyo, Japan) using a quarts cell of 0.5-mm pathlength. The CD spectra in methanol were measured at a peptide concentration of 1.10Â10 À4 M at room temperature. 1 H NMR spectra were measured in DMSO-d 6 at 30 1C (peptide concentration ca. 17 mg ml À1 ) on a JEOL JNM-ECP400 spectrometer (Jeol) using standard pulse sequences and software. The chemical shifts were determined with respect to internal TMS (tetramethylsilane).
cyclo(-Orn-Orn-Orn-D-Phe-Pro-) 2 6HBr (1) A protected linear precursor oxime, H-D-Phe-Pro-Orn(Z)-Orn(Z)-Orn(Z)-oxime, was prepared by using Boc-solid phase peptide synthesis on resin (Loading of oxime group: 0. 35 mmol g À1 resins). The formation of the cyclic peptide by the dimerization-cyclization of H-D-Phe-Pro-Orn(Z)-Orn(Z)-Orn(Z)-oxime on resin was performed in 1,4-dioxane with two equiv. of triethylamine and acetic acid for 1 day at room temperature. 10 The cyclizations gave cyclo(-Orn(Z)-Orn(Z)-Orn(Z)-D-Phe-Pro-) 2 in yield of 83%. The removal of all the masking groups was performed by 25% HBr/acetic acid. The product was purified by gel filtration on a Sephadex LH-20 column (GE Healthcare Bio-Sciences AB, Uppsala, Sweden), and by reprecipitation from methanol-ether to give a white powder of 1 in 53% yield.
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